Your prediction
Fresenius SE & Co. KGaA ADR Stock
The Fresenius SE & Co. KGaA ADR price is unchanged compared to yesterday.
Pros and Cons of Fresenius SE & Co. KGaA ADR in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius SE & Co. KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ADR | 0.000% | 1.786% | 11.765% | 5.556% | -3.390% | 55.102% | 2.703% |
| Fresenius SE & Co. KGaA | -0.130% | 0.751% | 10.162% | 6.392% | -4.008% | 55.585% | 2.995% |
| Fresenius Medical Care AG & Co KGaA ST | -1.660% | -0.653% | -2.145% | -0.869% | 0.711% | -13.797% | -39.721% |
| Universal Health Services B | -1.330% | 0.685% | 7.299% | -0.676% | -23.438% | 22.500% | 16.343% |
News
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Fresenius Medical Care AG & Co. KGaA? Here are five stocks we like better.
- Fresenius Medical Care reported solid Q2 results, with organic revenue up 5% and operating
Quest Diagnostics Q2 Earnings Call Highlights
Key Points
- Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.
- Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted